NCT01501916

Effect of Vitamin D3 on Cardiovascular Risk Factors

Effect of Vitamin D3 on Cardiovascular Risk Factors: a Randomized Trial in Human

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 250 (actual)
• Sponsor: Martin-Luther-Universität Halle-Wittenberg · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The aim of this study is to investigate whether a supplementation of Vitamin D3 can be used to reduce atherosclerotic risk factors.

Detailed description

It is the objective of this study to investigate whether a supplementation with Vitamin D3 can be used to reduce atherosclerotic risk factors such as hypertension, inflammation and hyperlipidemia. The research question is whether Vitamin D3 can lower blood pressure in mildly hypertensive subjects who are naive to antihypertensive medication, whether Vitamin D reduces the level of systemic inflammation and whether Vitamin D3 has an effect on blood lipids. major outcomes: \- decrease of systolic blood pressure in the treatment group in comparison with the placebo group

Conditions

• Hypertensive Disease
• Deficiency of Vitamin D3

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Vitamin D3	daily dosage of 50 µg Vitamin D3 for 8 weeks
DIETARY_SUPPLEMENT	Placebo	daily intake of placebo

Timeline

• Start date: 2012-12-01
• Primary completion: 2013-04-01
• Completion: 2013-12-01
• First posted: 2011-12-30
• Last updated: 2018-10-11